Evidence map›Paper›PMID 38519454›Full record

ArticleNature communications2024

Molecular basis promoting centriole triplet microtubule assembly.

Yutaka Takeda, Takumi Chinen, Shunnosuke Honda, Sho Takatori, Shotaro Okuda, Shohei Yamamoto, Masamitsu Fukuyama, Koh Takeuchi, Taisuke Tomita, Shoji Hata and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yutaka TakedaLaboratory of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, 113-0033, Japan.ORCID 0009-0001-2711-1822
Takumi ChinenLaboratory of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, 113-0033, Japan. takumi.chinen@mol.f.u-tokyo.ac.jp.ORCID 0000-0001-9836-8839
Shunnosuke HondaLaboratory of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, 113-0033, Japan.
Sho TakatoriLaboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, 113-0033, Japan.ORCID 0000-0002-3925-4011
Shotaro OkudaLaboratory of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, 113-0033, Japan.
Shohei YamamotoLaboratory of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, 113-0033, Japan.
Masamitsu FukuyamaLaboratory of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, 113-0033, Japan.
Koh TakeuchiLaboratory of Physical Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, 113-0033, Japan.ORCID 0000-0002-6227-4627
Taisuke TomitaLaboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, 113-0033, Japan.ORCID 0000-0002-0075-5943
Shoji HataLaboratory of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, 113-0033, Japan. s.hata@mol.f.u-tokyo.ac.jp.ORCID 0000-0003-4094-0489
Daiju KitagawaLaboratory of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, 113-0033, Japan. dkitagawa@mol.f.u-tokyo.ac.jp.ORCID 0000-0003-2509-5977
The University of Tokyo · JP

Funding

MEXT | Japan Science and Technology Agency (JST) JPMJCR22E1MEXT | Japan Science and Technology Agency (JST) JPMJPR21ECMEXT | Japan Society for the Promotion of Science (JSPS) 19H05651MEXT | Japan Society for the Promotion of Science (JSPS) 20K22701MEXT | Japan Society for the Promotion of Science (JSPS) 21H02623MEXT | Japan Society for the Promotion of Science (JSPS) 21J21492MEXT | Japan Society for the Promotion of Science (JSPS) 22K19305MEXT | Japan Society for the Promotion of Science (JSPS) 22K19370MEXT | Japan Society for the Promotion of Science (JSPS) 23H00394MEXT | Japan Society for the Promotion of Science (JSPS) 23H02627
6 · The paper itself

Abstract

The triplet microtubule, a core structure of centrioles crucial for the organization of centrosomes, cilia, and flagella, consists of unclosed incomplete microtubules. The mechanisms of its assembly represent a fundamental open question in biology. Here, we discover that the ciliopathy protein HYLS1 and the β-tubulin isotype TUBB promote centriole triplet microtubule assembly. HYLS1 or a C-terminal tail truncated version of TUBB generates tubulin-based superstructures composed of centriole-like incomplete microtubule chains when overexpressed in human cells. AlphaFold-based structural models and mutagenesis analyses further suggest that the ciliopathy-related residue D211 of HYLS1 physically traps the wobbling C-terminal tail of TUBB, thereby suppressing its inhibitory role in the initiation of the incomplete microtubule assembly. Overall, our findings provide molecular insights into the biogenesis of atypical microtubule architectures conserved for over a billion years.

Indexed as

CentriolesCiliopathiesCentrosomeCiliaHumansMicrotubulesProteinsTubulinHYLS1 protein, humanProteinsTubulin

Identifiers

PMID38519454
PMCPMC10960023
OpenAlexW4393096745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.